Outsourced Pharma Capacity Update Videos - Cell & Gene
-
Minaris Advanced Therapies Capacity Update July 2025: Cell & Gene Therapy
7/28/2025
With a robust track record of more than 7,500 GMP batches and proven platforms for multiple modalities, Minaris delivers speed, scalability, and reliability to help therapeutic developers bring cures to patients faster.
-
Excellos Capacity Update July 2025: Cell & Gene Therapy
7/28/2025
Excellos leverages its extensive starting material expertise as a key differentiator. Explore how our deep understanding of partner-sourced raw materials, quality control, and supply chain management creates significant value for our clients.
-
A Concept-To-Commercial Gene Therapy CDMO
7/28/2025
The Curator™ adherent platform has been used to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years and covering a variety of serotypes and indications.